Cargando…
To what degree are orphan drugs patient-centered? A review of the current state of clinical research in rare diseases
BACKGROUND: Over the past 30 years, the healthcare industry has increasingly turned its attention to rare diseases. Regulators have emphasized the need for clinical research in this area to be patient-centered. However, there is a lack of evidence concerning whether this need is actually met. In thi...
Autores principales: | Lanar, Sally, Acquadro, Catherine, Seaton, James, Savre, Isabelle, Arnould, Benoit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268539/ https://www.ncbi.nlm.nih.gov/pubmed/32493385 http://dx.doi.org/10.1186/s13023-020-01400-0 |
Ejemplares similares
-
Rare diseases: Canada’s “research orphans”
por: Gupta, Samir
Publicado: (2012) -
Assessing patients’ acceptance of their medication to reveal unmet needs: results from a large multi-diseases study using a patient online community
por: Lambert, Jérémy, et al.
Publicado: (2018) -
Incentives for orphan drug research and development in the United States
por: Seoane-Vazquez, Enrique, et al.
Publicado: (2008) -
Meiosis Research in Orphan and Non-orphan Tropical Crops
por: Bolaños-Villegas, Pablo, et al.
Publicado: (2019) -
The State’s Duty to the Orphan
por: Spratling, Edgar J.
Publicado: (1902)